<DOC>
	<DOCNO>NCT00001065</DOCNO>
	<brief_summary>To assess response toxicity patient fluconazole-resistant oral candidiasis ( thrush ) give initial induction amphotericin B oral suspension . Experience amphotericin B oral suspension drug-sensitive thrush HIV-infected patient limited encouraging .</brief_summary>
	<brief_title>A Study Amphotericin B Treatment Fungal Infections Mouth HIV-Infected Patients Who Have Not Had Success With Fluconazole</brief_title>
	<detailed_description>Experience amphotericin B oral suspension drug-sensitive thrush HIV-infected patient limited encouraging . Patients swish swallow amphotericin B oral suspension meal bedtime 14 day , time deem responder , nonresponder , failure induction therapy . Responders receive maintenance twice daily , nonresponders receive 14 day initial induction . Failures discontinue study . Responders 28 day induction place maintenance . After successful completion initial induction , patient remain study 6 month .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Oral</mesh_term>
	<mesh_term>Fluconazole</mesh_term>
	<mesh_term>Amphotericin B</mesh_term>
	<mesh_term>Liposomal amphotericin B</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection OR diagnosis AIDS . Diffuse oral candidiasis , symptomatic asymptomatic , resistant fluconazole . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Current symptom esophageal candidiasis unless negative endoscopic visualization biopsy Candida related yeast . Perioral lesion ( e.g. , angular stomatitis , perleche ) . Inability swish swallow oral solution . Inability tolerate oral therapy thrush . Concurrent Medication : Excluded : Fluconazole . Itraconazole . Ketoconazole . Flucytosine . Intravenous amphotericin nonstudy formulation . Nystatin . Clotrimazole . Other investigational antifungal agent . Systemic cytotoxic chemotherapy malignancy . Concurrent Treatment : Excluded : Radiation therapy mouth , neck , chest . Patients follow prior condition exclude : Esophageal candidiasis , proven presumptive , occur since fluconazole failure . Successful treatment thrush fluconazole &lt; = 200 mg/day original treatment failure . History oral candidiasis recur persisted despite IV amphotericin B give weekly . History anaphylaxis amphotericin B . History hypersensitivity component amphotericin B oral suspension . Prior Medication : Excluded within 6 week prior study entry : Cytotoxic therapy malignancy . Corticosteroids high replacement dos .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Administration , Oral</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Amphotericin B</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Candidiasis , Oral</keyword>
	<keyword>Suspensions</keyword>
</DOC>